Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Citius Pharmaceuticals, Inc. - Common Stock (NQ:CTXR)

0.5604 +0.0304 (+5.74%)
Streaming Delayed Price Updated: 2:49 PM EDT, May 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Citius Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Citius Pharmaceuticals (CTXR) Eyes Breakthrough with Late-Stage Drug Pipeline Poised for Regulatory Approval
Via AB Newswire
News headline image
Bloodstream Infections - From Threats to Solutions
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 11, 2024) - Investorideas.com, a go-to investing platform releases the second... 
Via Newsfile
Topics Death
Citius Pharmaceuticals (CTXR) Nears Key FDA Decisions and Launch Plans for 2024
Via AB Newswire
News headline image
Biopharma Stocks Transformative Innovation for the Future of Health
Vancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. - July 11, 2024) - Investorideas.com, a go-to investing platform releases the first... 
Via Newsfile
Topics Artificial Intelligence
News headline image
Citius Pharma's 'Antibiotic Lock' Effective In Patients With Catheter-Associated Bloodstream Infections ↗
Citius Pharmaceuticals' Phase 3 trial results for Mino-Lok, an antibiotic lock solution for central line-associated infections, show significant improvement in time to catheter failure and overall... 
Via Benzinga
News headline image
Yogi Tea Recalls: Yogi Brand Recalls 900,000 Tea Bags for Pesticide Residue ↗
Yogi Tea recalls are in effect for some of the company's tea bags over concerns of pesticide residue that may be found in them. 
Via InvestorPlace
Topics Product Recall
News headline image
VFS Stock Alert: VinFast Plunges on NHTSA Probe ↗
VinFast Auto stock is down on Tuesday as investors in VFS learn that the company is being investigated over a fatal crash last month. 
Via InvestorPlace
News headline image
Why Is Citius Pharmaceuticals (CTXR) Stock Up 11% Today? ↗
Citius Pharmaceuticals stock is up on Tuesday with heavy trading of CTXR shares alongside positive clinical trial results. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) Featured in Coverage of the EF Hutton Annual Global Conference
Via Investor Brand Network
News headline image
CTXR Stock Earnings: Citius Pharma Meets EPS for Q2 2024 ↗
CTXR stock results show that Citius Pharma met analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
Citius Pharmaceuticals (NASDAQ: CTXR) Advances Oncology Asset, Paving Way For Spin Out Of Advanced T-cell Lymphoma Treatment
Citius Pharmaceuticals (NASDAQ: CTXR) Advances Oncology Asset, Paving Way For Spin Out Of Advanced T-cell Lymphoma Treatment 
Via News Direct
Topics Death
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Thursday morning! 
Via InvestorPlace
News headline image
Sidoti Events, LLC’s Virtual November Micro-Cap Conference
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session ↗
Gainers Yellow Corporation (NASDAQ: YELL) shares jumped 106% to $1.46. The trucking company ceased operations on Sunday, according to a Wall Street Journal report. 
Via Benzinga
News headline image
Why Citius Pharmaceuticals Stock Is Plunging Today? ↗
The FDA issued a Complete Response Letter regarding Citius Pharmaceuticals Inc's (NASDAQ: CTXR) Biologics License Application (BLA) seeking approval for denileukin diftitox (Lymphir), an engineered... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why China Natural Resources Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
It's time to start off the week with a breakdown of the biggest pre-market stock movers worth watching for Monday morning! 
Via InvestorPlace
News headline image
CSX, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
U.S. stock futures traded mixed this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
Combination Therapy for Hemorrhoids: Citius' Combination Products Shows Meaningful Reduction In Symptoms ↗
Citius Pharmaceuticals Inc's (NASDAQ: CTXR) Halo-Lido, a topical treatment comprising lidocaine and halobetasol for hemorrhoid relief, significantly reduced symptom severity compared to individual  
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Citius Pharmaceuticals Approaches End Of Trial For Catheter-Related Bloodstream Infections – How Are Analysts Scoring Its Stock? ↗
The late-stage biopharma Citius Pharmaceuticals Inc. (NASDAQ: CTXR) is approaching the conclusion of the phase 3 trial for its drug, Mino-Lok. 
Via Benzinga
News headline image
Why Aaron's Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket ↗
Gainers ZeroFox Holdings, Inc. (NASDAQ: ZFOX) gained 36.7% to $1.49 in pre-market trading after dropping around 17% on Monday. ZeroFox completed the acquisition of LookingGlass Cyber Solutions, Inc. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
It's time for another dive into the biggest pre-market stock movers as we check out the latest news worth watching on Tuesday! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why FreightCar America Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket ↗
Gainers Biodexa Pharmaceuticals (NASDAQ: BDRX) shares rose 76% to $0.8276 in pre-market trading after gaining 65% on Monday. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.